Press releases

Month Year

Email alerts

Feb 19, 2016

Medtronic Named Among the World's Most Admired Companies by Fortune Magazine

Ranked Second Within Medical Products and Equipment Category

DUBLIN - February 19, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, has been designated as one of the World's Most Admired Companies by FORTUNE...
Feb 19, 2016

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2016

DUBLIN - February 19, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2016 fourth quarter cash dividend of $0.38 per ordinary share, representing a 25...
Feb 19, 2016

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016

DUBLIN - February 19, 2016 - Medtronic plc (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2016 on Tuesday, March 1, 2016. A news release will...
Feb 18, 2016

Meta-Analysis Shows Medtronic's Solitaire(TM) Stent Retriever Device Improves Functional Outcomes for Acute Ischemic Stroke Patients; Reduced Mortality in Patients 80+

SEER Pooled, Patient-Level Analysis of SWIFT PRIME, EXTEND-IA, ESCAPE and REVASCAT Shows Safety and Efficacy of Solitaire Device

DUBLIN - February 18, 2016 - A meta-analysis published online today in Stroke and presented at the International Stroke Conference (ISC) in Los Angeles, Calif., found that the addition of...
Feb 17, 2016

FDA Approves Medtronic Deep Brain Stimulation for People with Parkinson's Disease with Recent Onset of Motor Complications

Approval Expands Population of Individuals Who May Benefit From the Proven Therapy

DUBLIN - February 17, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Medtronic Deep Brain Stimulation (DBS) Therapy for use in people with...

Show per page